We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Psychodynamic Therapy for Treating Panic Disorder

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00128388
Recruitment Status : Completed
First Posted : August 9, 2005
Last Update Posted : June 27, 2013
Information provided by:

Study Description
Brief Summary:
This study will determine the effectiveness of a manualized form of brief psychodynamic psychotherapy in comparison with applied relaxation training in treating adults with panic disorder.

Condition or disease Intervention/treatment Phase
Panic Disorder Other: PFPP Other: ART Phase 2 Phase 3

Detailed Description:

This is a randomized controlled trial of a manualized form of brief psychodynamic psychotherapy in comparison with applied relaxation training, a less active form of treatment in other studies, for adults with primary Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) panic disorder.

Forty nine patients who have signed written consent who have primary DSM-IV panic disorder have been entered into the study. Randomization has been stratified by presence of major depression and use of psychoactive, anti-panic medications. Medications, if present, have been held constant. All patients have received 24 sessions of either psychodynamic psychotherapy, or applied relaxation training for panic disorder. This study is currently closed for recruitment, although final follow-up assessments have yet to be completed.

Study Design

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 49 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Randomized Controlled Trial of Psychodynamic Psychotherapy vs. Applied Relaxation for Panic Disorder
Study Start Date : February 2000
Primary Completion Date : January 2005
Study Completion Date : July 2005

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Panic Disorder
U.S. FDA Resources

Arms and Interventions

Arm Intervention/treatment
Experimental: 1 PFPP
Panic Focused Psychodynamic Psychotherapy
Other: PFPP
Psychoanalytic Psychotherapy for panic disorder
Other Name: Psychodynamic psychotherapy
Active Comparator: 2 ART
Applied Relaxation Training
Other: ART
Applied Relaxation Training
Other Names:
  • Applied Relaxation Training
  • Behavioral Therapy

Outcome Measures

Primary Outcome Measures :
  1. PDSS (panic disorder severity scale) [ Time Frame: termination, 2, 4, 6, 12 month f/u ]

Secondary Outcome Measures :
  1. SDS (Sheehan disability scale) [ Time Frame: termination, 2, 4, 6, 12 month f/u ]
  2. HARS (Hamilton anxiety rating scale) [ Time Frame: termination, 2, 4, 6, 12 month f/u ]
  3. HDRS (Hamilton depression rating scale) [ Time Frame: termination, 2, 4, 6, 12 month f/u ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 55 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • 18-55 years old
  • Primary DSM-IV panic disorder with or without agoraphobia
  • Severity 5/8 minimum on the Anxiety Disorders Interview Schedule

Exclusion Criteria:

  • Psychosis
  • Unstable medication dosage
  • Unwilling to discontinue ongoing psychotherapy
  • Organic mental syndrome
  • Substance use or abuse
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00128388

United States, New York
Weill Medical College
New York City, New York, United States, 10021
Sponsors and Collaborators
Weill Medical College of Cornell University
National Institute of Mental Health (NIMH)
Principal Investigator: Barbara Milrod, M.D. Weill Medical College
More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Barbara Milrod, M.D., Professor of Psychiatry, Weill Medical College of Cornell University
ClinicalTrials.gov Identifier: NCT00128388     History of Changes
Other Study ID Numbers: K23MH001849 ( U.S. NIH Grant/Contract )
First Posted: August 9, 2005    Key Record Dates
Last Update Posted: June 27, 2013
Last Verified: June 2013

Keywords provided by Weill Medical College of Cornell University:
panic disorder,
psychodynamic psychotherapy,
efficacy trial

Additional relevant MeSH terms:
Panic Disorder
Pathologic Processes
Anxiety Disorders
Mental Disorders